Ray will co-host a new podcast series, scheduled for release in late 2021, details to come.
For information about the Preventing Overdiagnosis webinar series, please visit here
Abstracts and registrations are now open for the Preventing Overdiagnosis international scientific conference, in Sydney December 5-7, 2019, which will be co-sponsored by the WHO. There are discounts for students and consumer/citizen advocates. For more information see here
The 7th international Preventing Overdiagnosis scientific conference will be in Sydney, December 5-7, 2019. Early bird registrations have just gone on sale, and there are discounted registrations for students and consumer/citizens organisations. The conference partners include universities from Australia, UK and USA, as well as one of the world’s leading medical journals, the BMJ. You can visit the conference website here.
Ray is now presenting Season Two of The Recommended Dose – produced by Cochrane Australia. The podcast is a series of intimate conversations with some of the world’s big thinkers in health, promoting a more questioning approach to healthcare. Guests include BMJ’s editor in chief Dr Fiona Godlee, the extraordinary Professor John Ioannidis, brilliant British novelist Sarah Moss, JAMA Internal Medicine’s editor in chief Professor Rita Redberg, Australia’s leading health reporter, Dr Norman Swan, and many more. Your can listen to it here
Leading healthcare groups in Australia, including professional organisations, consumer groups and public bodies have endorsed an Initial Statement, on overdiagnosis. The statement acknowledges that the problem of too much medicine is harming people and threatening healthcare sustainability – taking resources away from areas of genuine need. The statement followed a National Summit on overdiagnosis held at the University of Sydney in July, facilitated by the Wiser Healthcare research collaboration.
Dr Ray Moynihan has won a prestigious fellowship from the National Health and Medical Research Council to examine the increasingly recognized problem of overdiagnosis. The research fellowship will have a focus on how disease definitions are expanding and in some cases labeling many people unnecessarily. He is undertaking the fellowship with colleagues at Bond University’s Centre for Research in Evidence-Based Practice, under the supervision of globally respected Professor Paul Glasziou.
The 5th international Preventing Overdiagnosis conference will be in Quebec City, Quebec, from August 17 to 19, 2017, hosted by the Quebec Medical Association. For more information and to submit an abstract or register see: http://www.preventingoverdiagnosis.net/
A new paper published in the international open access scientific journal, PLOS ONE reports on the results of community focus groups with Australia women – investigating views about overdiagnosis and low bone density, or osteoporosis.
A commentary published in January in the leading United States medical journal, JAMA Internal Medicine, calls for much greater transparency and independence between patient advocacy groups and the pharmaceutical industry.